CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells

Stem Cells

Volumn 26, Issue 6, 2008, Pages 1464-1473

  Nelson, Timothy J ^a   Faustino, Randolph S ^a   Chiriac, Anca ^a   Crespo Diaz, Ruben ^a   Behfar, Atta ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

Biomarker; Cardiac differentiation; Cardiopoiesis; Network; Transcriptome

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR4; FIBROBLAST GROWTH FACTOR 4; MYOCARDIN; MYOCYTE ENHANCER FACTOR 2; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN MESP 1; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR MEF2C; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; CALCIUM; COMPLEMENTARY DNA; CXCR4 PROTEIN, MOUSE; RNA;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL REGENERATION; CELL SELECTION; CELL SUBPOPULATION; CONTROLLED STUDY; DNA FINGERPRINTING; EMBRYONIC STEM CELL; GENE OVEREXPRESSION; MESODERM; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; TISSUE SPECIFICITY; ANIMAL; CYTOLOGY; ENDODERM; GENE EXPRESSION PROFILING; GENETICS; HEART MUSCLE CELL; ISOLATION AND PURIFICATION; PHYSIOLOGY;

ANIMALS; BIOLOGICAL MARKERS; CALCIUM; CELL DIFFERENTIATION; DNA, COMPLEMENTARY; EMBRYONIC STEM CELLS; ENDODERM; GENE EXPRESSION PROFILING; MESODERM; MICE; MYOCYTES, CARDIAC; RECEPTORS, CXCR4; RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 48649099336     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0808     Document Type: Article

References (65)

1. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005;115:572-583.
2. Srivastava D, Ivey KN. Potential of stem-cell-based therapies for heart disease. Nature 2006;441:1097-1099.
3. Sanchez PL, San Roman JA, Villa A et al. Contemplating the bright future of stem cell therapy for cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006;3(Suppl 1):138-151.
4. Assmus B, Honold J, Schachinger V et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-1232.
5. Schachinger V, Erbs S, Elsasser A et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221.
6. Janssens S, Dubois C, Bogaert J et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006;367:113-121.
7. Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-1209.
8. Meyer GP, Wollert KC, Lotz J et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006;113:1287-1294.
9. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 2006;355:1274-1277.
10. Behfar A, Zingman LV, Hodgson DM et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 2002;16:1558-1566.
11. Perez-Terzic C, Behfar A, Mery A et al. Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circ Res 2003;92:444-452.
12. Kolossov E, Bostani T, Roell W et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 2006;203:2315-2327.
13. Hodgson DM, Behfar A, Zingman LV et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 2004;287:H471-479.
14. Min JY, Yang Y, Sullivan MF et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 2003;125:361-369.
15. Nelson TJ, Ge ZD, Van Orman J et al. Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. Anat Rec A Discov Mol Cell Evol Biol 2006;288:1216-1224.
16. Singla DK, Hacker TA, Ma L et al. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Cardiol 2006;40:195-200.
17. Menard C, Hagege AA, Agbulut O et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 2005;366:1005-1012.
18. Behfar A, Hodgson DM, Zingman LV et al. Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair. Ann Ny Acad Sci 2005;1049:189-198.
19. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005;23:845-856.
20. Solter D. From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research. Nat Rev Genet 2006;7:319-327.
21. Foley A, Mercola M. Heart induction: embryology to cardiomyocyte regeneration. Trends Cardiovasc Med 2004;14:121-125.
22. Garry DJ, Olson EN. A common progenitor at the heart of development. Cell 2006;127:1101-1104.
23. Wu SM, Chien KR, Mummery C. Origins and fates of cardiovascular progenitor cells. Cell 2008;132:537-543.
24. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005;6:826-835.
25. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell 2006;126:1037-1048.
26. Kirby ML. Molecular embryogenesis of the heart. Pediatr Dev Pathol 2002;5:516-543.
27. Behfar A, Perez-Terzic C, Faustino RS et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med 2007;204:405-420.
28. Chung S, Dzeja PP, Faustino RS et al. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med 2007;4 Suppl 1:S60-67.
29. Perez-Terzic C, Faustino RS, Boorsma BJ et al. Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery. Nat Clin Pract Cardiovasc Med 2007;4 Suppl 1:S68-76.
30. Mummery C, Ward-van Oostwaard D, Doevendans P et al. Differentiation of human embryonic stem cells to cardiomyocytes. Circulation 2003;107:2733-2740.
31. Smith AG, Heath JK, Donaldson DD et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988;336:688-690.
32. Faustino R, Behfar A, Perez-Terzic C et al. Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biol 2008;9:R6
33. Zou YR, Kottmann AH, Kuroda M et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393:595-599.
34. Tada S, Era T, Furusawa C et al. Characterization of mesendoderm: a diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture. Development 2005;132:4363-4374.
35. Yasunaga M, Tada S, Torikai-Nishikawa S et al. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotechnol 2005;23:1542-1550.
36. McGrath KE, Koniski AD, Maltby KM et al. Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev Biol 1999;213:442-456.
37. Yamaguchi TP, Dumont DJ, Conlon RA et al. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 1993;118:489-498.
38. Moretti A, Caron L, Nakano A et al. Multipotent embryonic Isl1(+) progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006;127:1151-1165.
39. Beqqali A, Kloots J, Ward-van Oostwaard D et al. Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. STEM CELLS 2006;24:1956-1967.
40. Ivanova NB, Dimos JT, Schaniel C et al. Lemischka IR. A stem cell molecular signature. Science 2002;298:601-604.
41. Ramalho-Santos M, Yoon S, Matsuzaki Y et al. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 2002;298:597-600.
42. Yusuf F, Rehimi R, Dai F et al. Expression of chemokine receptor CXCR4 during chick embryo development. Anat Embryol 2005;210:35-41.
43. Nagasawa T, Hirota S, Tachibana K et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382:635-638.
44. Kucia M, Ratajczak J, Ratajczak MZ. Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells. Biol Cell 2005;97:133-146.
45. Gorlin RJ, Gelb B, Diaz GA et al. WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies. Am J Med Genet 2000;91:368-376.
46. Hernandez PA, Gorlin RJ, Lukens JN et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003;34:70-74.
47. Taniuchi S, Yamamoto A, Fujiwara T et al. Dizygotic twin sisters with myelokathexis: mechanism of its neutropenia. Am J Hematol 1999;62:106-111.
48. Zhang D, Fan GC, Zhou X, et al. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 2008;44:281-292.
49. Zhang M, Mal N, Kiedrowski M et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 2007;21:3197-3207.
50. Yamashita JK, Takano M, Hiraoka-Kanie M et al. Prospective identification of cardiac progenitors by a novel single cell-based cardiomyocyte induction. FASEB J 2005;19:1534-1536.
51. Chen J, Kitchen CM, Streb JW et al. Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol 2002;34:1345-1356.
52. Wu SM, Fujiwara Y, Cibulsky SM et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006;127:1137-1150.
53. Kattman SJ, Huber TL, Keller GM. Multipotent flk-1(+) cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006;11:723-732.
54. Ema M, Takahashi S, Rossant J. Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors. Blood 2006;107:111-117.
55. Wang YX, Qian LX, Liu D et al. Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility. Cardiovasc Res 2007;74:290-303.
56. Cai CL, Zhou W, Yang L et al. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis. Development 2005;132:2475-2487.
57. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005;436:214-220.
58. McFadden DG, Barbosa AC, Richardson JA et al. The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner. Development 2005;132:189-201.
59. Xin M, Davis CA, Molkentin JD et al. A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc Natl Acad Sci U S A 2006;103:11189-11194.
60. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 2000;407:592-598.
61. Boon RA, Fledderus JO, Volger OL et al. KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1. Arterioscler Thromb Vasc Biol 2007;27:532-539.
62. Dekker RJ, Boon RA, Rondaij MG et al. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood 2006;107:4354-4363.
63. Engelman JA, Cantley LC. The role of the ErbB family members in non-small cell lung cancers sensitive to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res 2006;12:4372s-4376s.
64. Arrell DK, Niederländer NJ, Faustino RS et al. Cardioinductive network guiding stem cell differentiation revealed by proteomic cardiography of tumor necrosis factor α-primed endodermal secretome. STEM CELLS 2008;26:387-400.
65. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003;93:32-39.